Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,113.50
+89.00 (1.48%)
At close: Feb 9, 2026
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.6 trillion as of February 9, 2026. Its market cap has increased by 0.40% in one year.
Market Cap
1.60T
Enterprise Value
1.57T
Revenue
100.29B
Ranking
n/a
PE Ratio
64.37
Stock Price
6,113.50
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.60T, an increase of 78,470.52%. That is a compound annual growth rate of 33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.60T | -5.76% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Cipla | 1.07T |
| Zydus Lifesciences | 893.69B |
| Mankind Pharma | 850.46B |
| Aurobindo Pharma | 691.73B |
| Alkem Laboratories | 679.61B |
| Glenmark Pharmaceuticals | 546.00B |
| Laurus Labs | 513.16B |